Session Details
[DGP3]Discussion Group Poster Presentation
Fri. Mar 6, 2026 11:05 AM - 12:05 PM JST
Fri. Mar 6, 2026 2:05 AM - 3:05 AM UTC
Fri. Mar 6, 2026 2:05 AM - 3:05 AM UTC
Discussion Group Poster Presentation(1st Floor)
[DGP3-01]DG2025-78: Bioanalysis of Antibody–Drug Conjugate
*Yuji Fujita1, Shio Asami2, Hiroki Ichinose3, Ryosuke Shimamoto4, Kaori Nagumo5, Hiraku Hagita6, Masayoshi Mizuochi7, Kazuyuki Murata8, Masato Mori9, Ryo Yamato10, Yuichi Yokoyama11 (1. Astellas Pharma Inc., 2. Shionogi & Co., Ltd., 3. Taiho Pharmaceutical Co., Ltd., 4. Shin Nippon Biomedical Laboratories, Ltd., 5. Ono Pharmaceutical Co., Ltd., 6. Otsuka Pharmaceutical Co., Ltd., 7. CMIC Pharma Science Co., Ltd., 8. Sumika Chemical Analysis Service, Ltd., 9. Kowa Co., Ltd., 10. Mediford Corporation, 11. Tanabe Pharma Corporation)
[DGP3-02]DG2025-80: Ideal Organization and Testing Framework for Bioanalysis
*Yuya Hosokawa1, Miki Iimura2, Akane Katamoto3, Miyuki Tamura4, Naofumi Terada5, Kyoko Minoura6, Ayako Yamada7, Kyoko Watanabe8, Takashi Miyayama9 (1. Ono Pharmaceutical Co., Ltd., 2. Sunplanet Co.,Ltd., 3. Taiho Pharmaceutical Co., Ltd., 4. Sanwa Kagaku Kenkyusho Co., Ltd., 5. Sekisui Medical Co., Ltd., 6. Astellas Pharma Inc., 7. Shionogi TechnoAdvance Research CO., Ltd.：STAR, 8. Daiichi Sankyo Co., Ltd., 9. Chugai Pharmaceutical Co., Ltd.)
[DGP3-03]DG2025-82: Statistics Related to Bioanalysis 2
*Hironosuke Kurisu1, Kaori Ooka2, Yoshimi Tsujino3, Shota Yamada4 (1. Pfizer R&D Japan G. K., 2. Sumika Chemical Analysis Service, Ltd., 3. Toray Research Center, Inc., 4. CMIC Pharma Science Co., Ltd.)
[DGP3-04]DG2025-84: ICH M12 Guideline for Drug interaction studies - Deployment in Bioanalysis -
*Mizuki Horiuchi1, Takashige Okayama2, Yukari Kamikozawa3, Hiromi Sawada4, Kazuya Takano5, Kosuke Fukuda6, Shiori Honda7, Eriko Matsui8, Ryosuke Ide3 (1. Pfizer R&D Japan G.K., 2. Taiho Pharmaceutical Co., Ltd., 3. Tanabe Pharma Corporation, 4. Shionogi & Co., Ltd., 5. Sunplanet Co., Ltd., 6. Sumitomo Pharma Co., Ltd., 7. Kaken Pharmaceutical Co., Ltd., 8. CMIC Pharma Science Co., Ltd.)
[DGP3-05]DG2025-86: About LBA Practice - Comparison by Platform Features -
*Tomohiro Oka1, Itsuki Kuroiwa2, Yasuo Teramoto3, Hoshimi Okawa4, Ryosuke Yoshinaga5 (1. CMIC Pharma Science Co., Ltd., 2. Mediford Corporation, 3. Sumika Chemical Analysis Service, Ltd., 4. ONO Pharmaceutical Co., Ltd., 5. Toray Research Center, Inc.)
[DGP3-06]DG2025-88: [Basic DG] Knowledge, Experience, and Queries Required for LBA
*Akiko Kusaka1, Asako Usui2, Maya Suzuki3, Shinihchiro Matsuyama4 (1. Taiho Pharmaceutical Co., Ltd., 2. Shionogi & Co., Ltd., 3. Toray Research Center, Inc., 4. Mediford Corporation)